Short description
A clinical-stage company developing targeted therapeutics for cancer, inflammatory disorders, angio-proliferative diseases
Description
Developing targeted therapeutics for cancer, inflammatory disorders, and angio-proliferative diseases.
Total funding
$$3123123
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Founders
Paul Davis, Shaker Mousa